Dr. Reddy's Laboratories Ltd. | DRREDDY | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2017
2018
2019
2020
2021
Net Income
Net Income
15,537
13,504
22,920
18,857
28,835
Cash flow Operating Act...
Cash flow Operating Activities
21,44418,03028,70429,84136
Investments in PPE
Investments in PPE
-12,225-9,291-6,955-4,846-9,741
Cash flow Investing Act...
Net cash used for Investment Activities
-18,404-14,883-7,727-4,923-22,660
Dividend Paid
Dividend Paid
3,3903,9924,0023,9164,147
Cash flow Financing Act...
Net cash provided by Financing Activities
-3,692-4,440-21,326-25,159-298
Cash at beginning of period
Cash at beginning of period
4,9213,7782,5422,2281,962
Cash at end of period
Cash at end of period
3,7782,5422,2281,96214,820
Free Cash Flow
Free Cash Flow
9,219
8,739
21,749
24,995
-9,705